Timothée Klopfenstein

InstitutionNord Franche-Comté Hospital
AddressFrance
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 21 Covid-19 publications, with a maximum of 3 publications in June 2020
    All Publications
    Bar chart showing 27 publications over 6 distinct years, with a maximum of 12 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Timothée K, Gerazime A, Puyraveau M, Kadiane-Oussou NJ, Gendrin V, Zayet S. It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2022 02 11; 74(3):560-562. PMID: 34036334.
      Citations:    Fields:    
    2. Zayet S, Zahra H, Royer PY, Tipirdamaz C, Mercier J, Gendrin V, Lepiller Q, Marty-Quinternet S, Osman M, Belfeki N, Toko L, Garnier P, Pierron A, Plantin J, Messin L, Villemain M, Bouiller K, Klopfenstein T. Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in Nord Franche-Comté Hospital, France. Microorganisms. 2021 Aug 12; 9(8). PMID: 34442798.
      Citations: 3     
    3. Klopfenstein T, Gendrin V, Gerazime A, Conrozier T, Balblanc JC, Royer PY, Lohse A, Mezher C, Toko L, Guillochon C, Badie J, Pierron A, Kadiane-Oussou N'J, Puyraveau M, Zayet S. Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia. Infect Dis Ther. 2021 Sep; 10(3):1195-1213. PMID: 34247325.
      Citations: 3     
    4. Klopfenstein T, Gendrin V, Conrozier T, Gerazime A, Puyraveau M, Zayet S. Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'. Ann Rheum Dis. 2021 Jun 23. PMID: 34162593.
      Citations:    Fields:    
    5. Zayet S, Klopfenstein T, Ursulescu N, Belfeki N, Gendrin V, Osman M. Distinguishing coronavirus disease 2019 from influenza in children remains challenging. New Microbes New Infect. 2021 May; 41:100888. PMID: 33936745.
      Citations:    
    6. Klopfenstein T, Gendrin V, Kadiane-Oussou NJ, Conrozier T, Zayet S. Tocilizumab in COVID-19 pneumonia: Practical proposals based on a narrative review of randomised trials. Rev Med Virol. 2022 01; 32(1):e2239. PMID: 33882179.
      Citations:    Fields:    
    7. Osman M, Klopfenstein T, Belfeki N, Gendrin V, Zayet S. A Comparative Systematic Review of COVID-19 and Influenza. Viruses. 2021 03 10; 13(3). PMID: 33802155.
      Citations:    Fields:    Translation:HumansCells
    8. Zayet S, Royer PY, Toko L, Pierron A, Gendrin V, Klopfenstein T. Recurrence of COVID-19 after recovery ? A case series in health care workers, France. Microbes Infect. 2021 May-Jun; 23(4-5):104803. PMID: 33667643.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    9. Klopfenstein T, Conrozier T, Kadiane-Oussou NJ, Gendrin V, Zayet S. Is There Still a Place for Tocilizumab in Coronavirus Disease 2019? Open Forum Infect Dis. 2021 Feb; 8(2):ofab013. PMID: 33628858.
      Citations:    
    10. Royer PY, Zayet S, Jacquin-Porretaz C, Kadiane-Oussou NJ, Toko L, Gendrin V, Klopfenstein T. Angioedema and COVID-19: A New Dermatological Manifestation? Infect Dis Rep. 2021 Jan 01; 13(1):23-25. PMID: 33401389.
      Citations:    
    11. Zayet S, Gendrin V, Royer PY, Toko L, Kadiane-Oussou NJ, Klopfenstein T. Comparison of COVID-19 and influenza in adult patients: Neurological symptoms input. J Med Virol. 2021 04; 93(4):1893-1895. PMID: 33270276.
      Citations:    Fields:    Translation:Humans
    12. Zayet S, Gendrin V, Klopfenstein T. Natural history of COVID-19: back to basics. New Microbes New Infect. 2020 Nov; 38:100815. PMID: 33204429.
      Citations:    
    13. Zayet S, Klopfenstein T, Mezher C, Gendrin V, Conrozier T, Ben Abdallah Y. Coronavirus disease 2019 with spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema, France. New Microbes New Infect. 2020 Nov; 38:100785. PMID: 33072337.
      Citations: 4     
    14. Klopfenstein T, Zayet S, Lohse A, Selles P, Zahra H, Kadiane-Oussou NJ, Toko L, Royer PY, Balblanc JC, Gendrin V, Conrozier T. Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients. Int J Infect Dis. 2020 Oct; 99:491-495. PMID: 32798660.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    15. Klopfenstein T, Zahra H, Kadiane-Oussou NJ, Lepiller Q, Royer PY, Toko L, Gendrin V, Zayet S. New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France. Int J Infect Dis. 2020 Nov; 100:117-122. PMID: 32771635.
      Citations: 22     Fields:    Translation:HumansCellsPHPublic Health
    16. Conrozier T, Lohse A, Balblanc JC, Dussert P, Royer PY, Bossert M, Bozgan AM, Gendrin V, Charpentier A, Toko L, Badie J, Mezher C, Roux MF, Kadiane-Oussou NJ, Contreras R, Kessler J, Mazurier I, Klopfenstein T, Zayet S. Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration. Clin Exp Rheumatol. 2020 Jul-Aug; 38(4):742-747. PMID: 32573419.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    17. Lohse A, Klopfenstein T, Balblanc JC, Royer PY, Bossert M, Gendrin V, Charpentier A, Bozgan AM, Badie J, Bourgoin C, Contreras R, Mazurier I, Conrozier T, Zayet S. Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19). Microbes Infect. 2020 10; 22(9):500-503. PMID: 32574789.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    18. Zayet S, Kadiane-Oussou NJ, Lepiller Q, Zahra H, Royer PY, Toko L, Gendrin V, Klopfenstein T. Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster. Microbes Infect. 2020 10; 22(9):481-488. PMID: 32561409.
      Citations: 44     Fields:    Translation:HumansCellsPHPublic Health
    19. Zayet S, Klopfenstein T, Kov?cs R, Stancescu S, Hagenkötter B. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020. Emerg Infect Dis. 2020 Sep; 26(9). PMID: 32453685.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
    20. Klopfenstein T, Zayet S, Lohse A, Balblanc JC, Badie J, Royer PY, Toko L, Mezher C, Kadiane-Oussou NJ, Bossert M, Bozgan AM, Charpentier A, Roux MF, Contreras R, Mazurier I, Dussert P, Gendrin V, Conrozier T. Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients. Med Mal Infect. 2020 Aug; 50(5):397-400. PMID: 32387320.
      Citations: 105     Fields:    Translation:HumansCellsPHPublic Health
    21. Klopfenstein T, Kadiane-Oussou NJ, Royer PY, Toko L, Gendrin V, Zayet S. Diarrhea: An underestimated symptom in Coronavirus disease 2019. Clin Res Hepatol Gastroenterol. 2020 06; 44(3):282-283. PMID: 32371006.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    22. Klopfenstein T, Kadiane-Oussou NJ, Toko L, Royer PY, Lepiller Q, Gendrin V, Zayet S. Features of anosmia in COVID-19. Med Mal Infect. 2020 Aug; 50(5):436-439. PMID: 32305563.
      Citations: 112     Fields:    Translation:HumansCellsPHPublic Health
    Klopfenstein's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (102)
    Explore
    _
    Co-Authors (58)
    Explore
    _
    Similar People (60)
    Explore
    _